KPNA3

Importin subunit alpha-4 · O00505 · KPNA3 on Sugi Atlas →

1,894 patent compounds predicted against KPNA3, 1,677 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Molibresib Molibresib (SCHEMBL1872390) 1.00 1/20
Molibresib Molibresib (SCHEMBL12671490) 1.00 1/20
Molibresib Molibresib (SCHEMBL12966358) 1.00 1/20
SCHEMBL9998851 SCHEMBL9998851 0.91 1/20
SCHEMBL14756282 SCHEMBL14756282 0.88 1/20
SCHEMBL15980874 SCHEMBL15980874 0.88 1/20
SCHEMBL12966165 SCHEMBL12966165 0.87 1/20
SCHEMBL14756215 SCHEMBL14756215 0.87 1/20
SCHEMBL14756339 SCHEMBL14756339 0.87 1/20
SCHEMBL15980861 SCHEMBL15980861 0.87 1/20
SCHEMBL9998825 SCHEMBL9998825 0.86 1/20
SCHEMBL15980893 SCHEMBL15980893 0.86 1/20
SCHEMBL15980803 SCHEMBL15980803 0.86 1/20
SCHEMBL1874116 SCHEMBL1874116 0.85 1/20
SCHEMBL12671221 SCHEMBL12671221 0.85 1/20
SCHEMBL14756021 SCHEMBL14756021 0.85 1/20
SCHEMBL14756240 SCHEMBL14756240 0.85 1/20
SCHEMBL14756287 SCHEMBL14756287 0.85 1/20
SCHEMBL14756335 SCHEMBL14756335 0.85 1/20
SCHEMBL14756409 SCHEMBL14756409 0.85 1/20

Clinical trials — most relevant to KPNA3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection PHASE3COMPLETED
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma PHASE1/PHASE2RECRUITING
Efficacy of Ivermectin in COVID-19 PHASE1/PHASE2COMPLETED
Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome PHASE2COMPLETED
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion nanRECRUITING
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX) nanUNKNOWN
Chordoma Family Study nanCOMPLETED
Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) nanWITHDRAWN
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Induced Pluripotent Stem Cells for Niemann Pick Disease nanCOMPLETED
Biomarker for Niemann Pick Type C Disease (BioNPC) nanWITHDRAWN
Genetics of Ehlers-Danlos Syndrome nanCOMPLETED
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum nanCOMPLETED
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam nanUNKNOWN
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Phenotype/Genotype Correlations in Neuromuscular Disorders nanCOMPLETED
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East nanUNKNOWN
Nerve Ultrasound in Acquired and Genetic Sensory Neuronopathies nanNOT_YET_RECRUITING
Mackenzie's Mission: The Australian Reproductive Carrier Screening Project nanCOMPLETED
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders nanRECRUITING
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
Whole Genome Sequencing in the Neonatal Intensive Care Unit nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a KPNA3 binder may also engage these)

ProteinNameSimilarity
O35344 1.000 O35344 →
P52295 1.000 P52295 →
KPNA4 Importin subunit alpha-3 1.000 landscape →
O14063 1.000 O14063 →
A9QM74 1.000 A9QM74 →
O35343 1.000 O35343 →
O94374 0.999 O94374 →
Q9FWY7 0.998 Q9FWY7 →
Q02821 0.998 Q02821 →
Q76P29 0.997 Q76P29 →
P52171 0.997 P52171 →
C6K7I2 0.997 C6K7I2 →
B6HJ92 0.996 B6HJ92 →
O80480 0.996 O80480 →
Q19969 0.995 Q19969 →
P52170 0.994 P52170 →
O04294 0.993 O04294 →
G5EB89 0.992 G5EB89 →
Q9FJ09 0.992 Q9FJ09 →
P91276 0.992 P91276 →
C0LLJ0 0.989 C0LLJ0 →
C1JZ66 0.989 C1JZ66 →
Q557F4 0.988 Q557F4 →
KPNA2 Importin subunit alpha-1 0.988 landscape →
Q9M9X7 0.988 Q9M9X7 →
O14089 0.986 O14089 →
P52293 0.983 P52293 →
F4JL11 0.982 F4JL11 →
Q8H0U4 0.981 Q8H0U4 →
Q06142 0.980 Q06142 →